6-Methoxy-1H-indazole is an organic compound characterized by its indazole core, which is a bicyclic structure consisting of a five-membered ring fused to a six-membered ring. The presence of a methoxy group (-OCH3) at the 6-position of the indazole ring significantly influences its chemical properties and reactivity. This compound is typically a white to off-white solid and is soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO), but may have limited solubility in water. It is often used in research settings, particularly in medicinal chemistry, due to its potential biological activities, including anti-inflammatory and anticancer properties. The compound's molecular structure allows for various interactions with biological targets, making it a subject of interest in drug development. As with many organic compounds, proper handling and storage are essential to maintain its stability and prevent degradation. Safety data sheets should be consulted for information on toxicity and safe handling practices.

6-Methoxy-1H-indazole

3522-07-4: 1H-Indazole, 6-methoxy-, 2H-Indazole, 6-methoxy-, 6-Methoxy-2H-indazole, 6-Methoxyindazole, 7/4/3522, T56 Bmnj Ho1

6-Methoxy-1H-indazole (6MI) is an inhibitor of the enzyme tyrosine hydroxylase, which is responsible for the conversion of tyrosine to L-DOPA. It also has neuroprotective properties. 6MI has been shown to be neuroprotective in a number of different animal models and has been found to be a potent inhibitor of mao-a. 6MI may have potential as a therapeutic agent for Parkinson's disease due to its neuroprotective properties and interaction with mao-a.

CAS 3522-07-4: 6-Methoxy-1H-indazole

6-Methoxy-1H-indazole

Ref: 3D-FM147699

6-Methoxy-1H-indazole

Ref: 54-OR302496

6-Methoxy-1H-indazole

Ref: IN-DA003N9B

6-Methoxy-1H-indazole

Ref: 10-F079990